Task: Answer the multiple choice question.
Question: Which compound exhibits a -31.954% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a O=C1C2CCCN2C(c2ccc(Cl)cc2)N1c1nccs1
b CCSc1nc2c(c(=O)n1Cc1ccccc1)SC(C)C2
c CC(C)CC(=O)NC(Sc1ccc(Cl)cc1)C(Cl)(Cl)Cl
Answer: c. CC(C)CC(=O)NC(Sc1ccc(Cl)cc1)C(Cl)(Cl)Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CC(=O)NC(Sc1ccc(Cl)cc1)C(Cl)(Cl)Cl
CC(C)CC(=O)NC(Sc1ccc(Cl)cc1)C(Cl)(Cl)Cl
3-methyl-N-[2,2,2-trichloro-1-(4-chlorophenyl)sulfanylethyl]butanamide